StockData
Caris Life Sciences, Inc. logo

Caris Life Sciences, Inc. (CAI) stock

CAINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/3093% above fair value
$19.94−1.06 (-5.05%)

Close on Nov 17, 2026Market cap $5.63BP/E –Yield –

Caris Life Sciences total assets

Total assets on the balance sheet at the end of each period.

Caris Life Sciences's total assets was $1.26B at Sep 30, 2026. For fiscal 2025 it was $1.13B, up 227.5% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.13B+227.5%
FY2024Dec 31, 2024$343.73M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.26B+27.5%
Q2 FY2026Jun 30, 2026$1.23B+28.7%
Q1 FY2026Mar 31, 2026$1.16B+238.2%
Q4 FY2025Dec 31, 2025$1.13B–
Q3 FY2025Sep 30, 2025$984.57M–
Q2 FY2025Jun 30, 2025$955.06M–
Q4 FY2024Dec 31, 2024$343.73M–

More Caris Life Sciences figures

See a number that looks wrong?